News Search Results
Jun 11, 2025, 10:15 ET Dental Soft-tissue Regeneration Market worth $0.53 billion in 2030 with 6.8% CAGR | MarketsandMarkets™
Synthetic Biology Market Get access to the latest updates on
More news about: MarketsandMarkets
Jun 05, 2025, 10:30 ET Oligonucleotide Synthesis Market worth US$24.7 billion by 2030 with 10.8% CAGR | MarketsandMarkets™
in therapeutics & diagnostics. This growth is supported by technological advancements and rising investments in life sciences research and synthetic biology. Additionally, the growing emphasis on precision and personalized medicine contributes to this expansion, creating new opportunities as key players
More news about: MarketsandMarkets
Jun 03, 2025, 10:30 ET MATTERWORKS INC. SECURES SERIES A FUNDING TO ADVANCE MACHINE INTELLIGENCE FOR PREDICTIVE BIOLOGY
specialize in early stage investments at the intersection of biology, big data, and Al, with a focus on therapeutics, bio tools, diagnostics, and synthetic biology platforms.
More news about: Matterworks
Jun 02, 2025, 22:46 ET AmphiStar and Kensing Announce Strategic Partnership to Bring Upcycled Biosurfactants to the North American Personal Care Market
biosurfactants are the result of an IP-backed breakthrough technology featuring an unprecedented combination in the surfactant landscape: advanced synthetic biology, waste processing and continuous biomanufacturing principles.By eliminating reliance on fossil feedstocks and resource-intensive crops,
More news about: Kensing LLC
May 30, 2025, 10:09 ET HH Chemical Launches BIODEX® -- The World's First Fully Integrated Bio-Based Materials Brand Tackling Multi-Industry Challenges Through Innovation
Chemical and the National University of Singapore (NUS), under the SINERGY (Singapore Consortium for Synthetic Biology). Leveraging palm oil byproducts and HH Chemical's proprietary biosynthesis platform, the BIODEX® series was patented and scaled for commercial
More news about: HH CHEMICAL
May 29, 2025, 16:30 ET Amyris Takes Full Ownership of Brazilian Industrial Fermentation Plant and Invests in Completion of Fourth Precision Fermentation Line
Calif., May 29, 2025 /PRNewswire/ -- Amyris, Inc., a vertically integrated synthetic biology company and leading innovator in the field of industrial biotechnology, today announced that it has acquired Ingredion's 31% stake in the RealSweet
More news about: Amyris, Inc.
May 29, 2025, 16:30 ET Amyris and Ingredion Wind Down RealSweet Joint Venture
Ill., May 29, 2025 /PRNewswire/ -- Amyris, Inc., a vertically integrated synthetic biology company and leading innovator in the field of industrial biotechnology, and Ingredion Incorporated (NYSE: INGR), a leading global provider of
More news about: Amyris, Inc.
May 29, 2025, 10:45 ET Precision Fermentation Ingredients Market worth $36.31 billion by 2030- Exclusive Report by MarketsandMarkets™
toward ethical consumption, requirements to lower greenhouse gas emissions related to conventional animal farming, and process advancements in synthetic biology that provide cost-efficient and scalable manufacturing of functional ingredients like proteins,
More news about: MarketsandMarkets
May 21, 2025, 22:38 ET MGI Tech Unveils Next-Generation Automation Portfolio at SLAS Europe 2025 in Germany
advanced robotics, AI integration, and modular platforms, MGI's automation portfolio addresses critical challenges in genomics, drug discovery, synthetic biology, and molecular diagnostics—empowering labs of all sizes to scale research efficiently. PrepALL: Compact, Affordable Automation for Flexible Pipetting
More news about: MGI TECH
May 21, 2025, 16:05 ET Ginkgo Bioworks Announces Appointment of Steven Coen as Chief Financial Officer
business opportunities, including with respect to our solutions and tools offerings, (iv) the risk of downturns in demand for products using synthetic biology, (v) the uncertainty regarding the demand for passive monitoring programs and biosecurity services, (vi) changes to the biosecurity industry,
More news about: Ginkgo Bioworks
May 19, 2025, 12:17 ET Persist AI Launches Cloud Lab to Accelerate Pharmaceutical Formulation Development, Raises $12M Series A Funding
development. Prior to founding Persist, Raman was part of the automation team at Zymergen, developing the next generation robotic factory for synthetic biology. Co-founder Christopher Shelner serves as Chief Operating Officer, with significant expertise in automation design,
More news about: Persist AI Formulations
May 13, 2025, 11:00 ET Integra Therapeutics announces new pre-clinical data at 28th Annual Meeting of American Society of Gene and Cell Therapy (ASGCT)
unsupervised variability generation approach. Over 400,000 variants are tested using a proprietary high- throughput screening system grounded in synthetic biology principles. Our system compared favourably against existing systems like homology-directed repair (HDR) or homology-independent targeted insertion
More news about: Integra Therapeutics
May 07, 2025, 13:30 ET Israel's Mileutis Appoints Industry Leaders Dr. Joachim Hasenmaier and Mr. Aaron Schacht to Board of Directors
Aaron Schacht is the CEO of BiomEdit, Inc., a private biotech company backed by the Gates Foundation, which develops microbiome and synthetic biology innovations for animal health. Previously, he led R&D and Business Development at Elanco Animal Health, where he oversaw major acquisitions
More news about: Mileutis Ltd.
May 07, 2025, 11:02 ET GenoFAB Announces Publication of Groundbreaking Self-Documenting Plasmid Technology In Trends In Biotechnology
(970) 817-2400 x800, [email protected] About GenoFAB: GenoFAB is a synthetic biology platform dedicated to helping life scientists write and debug their ideas in DNA. With roots in academic research and a commitment to reproducibility,
More news about: GenoFAB
May 07, 2025, 08:00 ET Invaio Sciences, a Flagship Pioneering Company, Appoints Magalie Guilhabert as Chief Science Officer
overseeing a team of 100 scientists and technicians and managing a $41 million revenue target. Her leadership in synthetic biology, microbial genetics, and data science drove the development of a cutting-edge agricultural solutions portfolio, aligning scientific innovation
More news about: Invaio Sciences
May 06, 2025, 17:00 ET Ginkgo Bioworks Reports First Quarter 2025 Financial Results
business opportunities, including with respect to our solutions and tools offerings, (iv) the risk of downturns in demand for products using synthetic biology, (v) the uncertainty regarding the demand for passive monitoring programs and biosecurity services, (vi) changes to the biosecurity industry,
More news about: Ginkgo Bioworks
May 05, 2025, 07:15 ET Atlas Data Storage Announces Initial Close of Seed Financing
extremely high data density, 1,000+ year durability, unlimited low-cost copies, and scalability. The company is spearheading the convergence of synthetic biology and information technology. Atlas' core technology combines novel semiconductor chips and enzyme engineering, ushering in a new era of high-throughput
More news about: Atlas Data Storage
May 02, 2025, 07:30 ET Darnatein to Present at 14th International BMP Conference Highlighting Advances in Regenerative Biologics
OSRH) focused on the development of design-augmented biologics for regenerative medicine. The company's proprietary platform harnesses synthetic biology and protein engineering to create next-generation growth factors for musculoskeletal and tissue repair. Lead candidates DRT-101 and DRT-102 are
More news about: OSR Holdings Inc.
Apr 30, 2025, 09:00 ET Phytolon and Ginkgo Bioworks Boost Natural Food Colors by Hitting Full-Project Milestone, Nearly Tripling the Manufacturing Efficiency of Phytolon's Innovative Colors
business opportunities, including with respect to our solutions and tools offerings, (iv) the risk of downturns in demand for products using synthetic biology, (v) the uncertainty regarding the demand for passive monitoring programs and biosecurity services, (vi) changes to the biosecurity industry,
More news about: Ginkgo Bioworks
Apr 26, 2025, 21:40 ET Bestzyme's Mellia™ Brazzein Receives FDA "No Questions" Letter, Bringing Creative Sugar Reduction Solution to Global Market
research, development, and industrialization of enzymes, functional proteins, and biopharmaceutical raw materials. By leveraging its proprietary synthetic biology technology platform, Bestzyme has established a comprehensive system covering molecular design, strain engineering, and process scaling. The company
More news about: GenScript Biotech Corporation
Apr 22, 2025, 09:00 ET Ginkgo Automation Partners with Aura Genetics to Accelerate Direct-to-Consumer Testing and Innovation
business opportunities, including with respect to our solutions and tools offerings, (iv) the risk of downturns in demand for products using synthetic biology, (v) the uncertainty regarding the demand for passive monitoring programs and biosecurity services, (vi) changes to the biosecurity industry,
More news about: Ginkgo Bioworks